Skip to main content
PMC home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 1995 Sep;32(9):724–727. doi: 10.1136/jmg.32.9.724

Fetal valproate syndrome.

J Clayton-Smith 1, D Donnai 1
PMCID: PMC1051674  PMID: 8544193

Full text

PDF
724

Images in this article

725Image
on p.725
725Image
on p.725
725Image
on p.725
726Image
on p.726
726Image
on p.726
726Image
on p.726

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ardinger H. H., Atkin J. F., Blackston R. D., Elsas L. J., Clarren S. K., Livingstone S., Flannery D. B., Pellock J. M., Harrod M. J., Lammer E. J. Verification of the fetal valproate syndrome phenotype. Am J Med Genet. 1988 Jan;29(1):171–185. doi: 10.1002/ajmg.1320290123. [DOI] [PubMed] [Google Scholar]
  2. Chitayat D., Farrell K., Anderson L., Hall J. G. Congenital abnormalities in two sibs exposed to valproic acid in utero. Am J Med Genet. 1988 Oct;31(2):369–373. doi: 10.1002/ajmg.1320310214. [DOI] [PubMed] [Google Scholar]
  3. Dalens B., Raynaud E. J., Gaulme J. Teratogenicity of valproic acid. J Pediatr. 1980 Aug;97(2):332–333. doi: 10.1016/s0022-3476(80)80517-8. [DOI] [PubMed] [Google Scholar]
  4. DiLiberti J. H., Farndon P. A., Dennis N. R., Curry C. J. The fetal valproate syndrome. Am J Med Genet. 1984 Nov;19(3):473–481. doi: 10.1002/ajmg.1320190308. [DOI] [PubMed] [Google Scholar]
  5. Dieterich E., Steveling A., Lukas A., Seyfeddinipur N., Spranger J. Congenital anomalies in children of epileptic mothers and fathers. Neuropediatrics. 1980 Aug;11(3):274–283. doi: 10.1055/s-2008-1071396. [DOI] [PubMed] [Google Scholar]
  6. Felding I., Rane A. Congenital liver damage after treatment of mother with valproic acid and phenytoin? Acta Paediatr Scand. 1984 Jul;73(4):565–568. doi: 10.1111/j.1651-2227.1984.tb09974.x. [DOI] [PubMed] [Google Scholar]
  7. Hanson J. W., Smith D. W. The fetal hydantoin syndrome. J Pediatr. 1975 Aug;87(2):285–290. doi: 10.1016/s0022-3476(75)80604-4. [DOI] [PubMed] [Google Scholar]
  8. Huot C., Gauthier M., Lebel M., Larbrisseau A. Congenital malformations associated with maternal use of valproic acid. Can J Neurol Sci. 1987 Aug;14(3):290–293. doi: 10.1017/s0317167100026639. [DOI] [PubMed] [Google Scholar]
  9. Hurd R. W., Wilder B. J., Van Rinsvelt H. A. Valproate, birth defects, and zinc. Lancet. 1983 Jan 22;1(8317):181–181. doi: 10.1016/s0140-6736(83)92775-7. [DOI] [PubMed] [Google Scholar]
  10. Jäger-Roman E., Deichl A., Jakob S., Hartmann A. M., Koch S., Rating D., Steldinger R., Nau H., Helge H. Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acid. J Pediatr. 1986 Jun;108(6):997–1004. doi: 10.1016/s0022-3476(86)80949-0. [DOI] [PubMed] [Google Scholar]
  11. Lindhout D., Schmidt D. In-utero exposure to valproate and neural tube defects. Lancet. 1986 Jun 14;1(8494):1392–1393. doi: 10.1016/s0140-6736(86)91711-3. [DOI] [PubMed] [Google Scholar]
  12. Martínez-Frías M. L. Clinical manifestation of prenatal exposure to valproic acid using case reports and epidemiologic information. Am J Med Genet. 1990 Oct;37(2):277–282. doi: 10.1002/ajmg.1320370224. [DOI] [PubMed] [Google Scholar]
  13. Mastroiacovo P., Bertollini R., Morandini S., Segni G. Maternal epilepsy, valproate exposure, and birth defects. Lancet. 1983 Dec 24;2(8365-66):1499–1499. doi: 10.1016/s0140-6736(83)90844-9. [DOI] [PubMed] [Google Scholar]
  14. O'Donoghue P. Relaxation in cerebral palsy. Dev Med Child Neurol. 1988 Feb;30(1):115–117. doi: 10.1111/j.1469-8749.1988.tb04733.x. [DOI] [PubMed] [Google Scholar]
  15. Robert E., Rosa F. Valproate and birth defects. Lancet. 1983 Nov 12;2(8359):1142–1142. doi: 10.1016/s0140-6736(83)90656-6. [DOI] [PubMed] [Google Scholar]
  16. Sharony R., Garber A., Viskochil D., Schreck R., Platt L. D., Ward R., Buehler B. A., Graham J. M., Jr Preaxial ray reduction defects as part of valproic acid embryofetopathy. Prenat Diagn. 1993 Oct;13(10):909–918. doi: 10.1002/pd.1970131005. [DOI] [PubMed] [Google Scholar]
  17. Thisted E., Ebbesen F. Malformations, withdrawal manifestations, and hypoglycaemia after exposure to valproate in utero. Arch Dis Child. 1993 Sep;69(3 Spec No):288–291. doi: 10.1136/adc.69.3_spec_no.288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Valproate and spina bifida. Lancet. 1989 Mar 18;1(8638):611–612. [PubMed] [Google Scholar]
  19. Van Allen M. I., Kalousek D. K., Chernoff G. F., Juriloff D., Harris M., McGillivray B. C., Yong S. L., Langlois S., MacLeod P. M., Chitayat D. Evidence for multi-site closure of the neural tube in humans. Am J Med Genet. 1993 Oct 1;47(5):723–743. doi: 10.1002/ajmg.1320470528. [DOI] [PubMed] [Google Scholar]
  20. Verloes A., Frikiche A., Gremillet C., Paquay T., Decortis T., Rigo J., Senterre J. Proximal phocomelia and radial ray aplasia in fetal valproic syndrome. Eur J Pediatr. 1990 Jan;149(4):266–267. doi: 10.1007/BF02106290. [DOI] [PubMed] [Google Scholar]
  21. Winter R. M., Donnai D., Burn J., Tucker S. M. Fetal valproate syndrome: is there a recognisable phenotype? J Med Genet. 1987 Nov;24(11):692–695. doi: 10.1136/jmg.24.11.692. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES